Cargando…

Health-Related Quality of Life in Patients With Locally Advanced Gastric Cancer Undergoing Perioperative or Postoperative Adjuvant S-1 Plus Oxaliplatin With D2 Gastrectomy: A Propensity Score-Matched Cohort Study

BACKGROUND: Some high-quality clinical trials have proven the efficacy and safety of perioperative and postoperative S-1 with oxaliplatin (peri-SOX and post-SOX) for patients with locally advanced gastric cancer (LAGC) undergoing D2 gastrectomy. However, little is known about how health-related qual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jianhong, Wang, Zaozao, Li, Zhexuan, Liu, Ying, Fan, Yingcong, Di, Jiabo, Cui, Ming, Xing, Jiadi, Zhang, Chenghai, Yang, Hong, Yao, Zhendan, Zhang, Nan, Chen, Lei, Liu, Maoxing, Xu, Kai, Tan, Fei, Gao, Pin, Su, Xiangqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013949/ https://www.ncbi.nlm.nih.gov/pubmed/35444949 http://dx.doi.org/10.3389/fonc.2022.853337

Ejemplares similares

Surgical and oncological efficacy of laparoscopic-assisted total gastrectomy versus open total gastrectomy for gastric cancer by propensity score matching: a retrospective comparative study
por: Fan, Yingcong, et al.
Publicado: (2021)

Risk factors for esophagojejunal anastomotic leakage after curative total gastrectomy combined with D2 lymph node dissection for gastric cancer
por: Xing, Jiadi, et al.
Publicado: (2021)

Safety and efficacy of laparoscopic gastrectomy in obese patients with gastric cancer
por: Liu, Maoxing, et al.
Publicado: (2019)

GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
por: Wang, Zaozao, et al.
Publicado: (2014)

Long-term health-related quality of life in patients with gastric cancer after total or distal gastrectomy: a propensity score-matched cohort study
por: Yu, Jianhong, et al.
Publicado: (2023)

Modified π-shaped esophagojejunostomy in totally laparoscopic total gastrectomy: a report of 40 consecutive cases from a single center
por: Xing, Jiadi, et al.
Publicado: (2022)

Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study
por: Chen, Lei, et al.
Publicado: (2021)

Application of Near-Infrared Fluorescence Imaging with Indocyanine Green in Totally Laparoscopic Distal Gastrectomy
por: Liu, Maoxing, et al.
Publicado: (2020)

Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study
por: Yang, Hong, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio as an Early Predictor of Symptomatic Anastomotic Leakage in Patients after Rectal Cancer Surgery: A Propensity Score-Matched Analysis
por: Tan, Fei, et al.
Publicado: (2022)

The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study
por: Zhang, Chenghai, et al.
Publicado: (2022)

Short-Term and Long-Term Outcomes Following Transhiatal versus Right Thoracoabdominal Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction
por: Xing, Jiadi, et al.
Publicado: (2020)

Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Disease-Specific Survival after R0 Resection in a Chinese Gastric Cancer Population
por: Chen, Donglai, et al.
Publicado: (2013)

Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer
por: Wang, Zaozao, et al.
Publicado: (2017)

Risk factors of symptomatic anastomotic leakage and its impacts on a long-term survival after laparoscopic low anterior resection for rectal cancer: a retrospective single-center study
por: Qi, Xinyu, et al.
Publicado: (2021)

Short- and long-term outcomes of rectal cancer patients with high or improved low ligation of the inferior mesenteric artery
por: Zhang, Chenghai, et al.
Publicado: (2020)

Clinicopathological characteristics and treatment outcome of resectable gastric cancer patients with small para-aortic lymph node
por: Yao, Zhendan, et al.
Publicado: (2023)

Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
por: Ren, Deng-Feng, et al.
Publicado: (2018)

Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial
por: Wang, Zaozao, et al.
Publicado: (2018)

Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO‐CLASSIC Study
por: Yu, Yiyi, et al.
Publicado: (2019)

Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy
por: Yang, Hong, et al.
Publicado: (2022)

Genomic profiling of colorectal cancer with isolated lung metastasis
por: Zhang, Nan, et al.
Publicado: (2020)

Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer
por: Lee, Ha Yeon, et al.
Publicado: (2016)

Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
por: Fuse, Nozomu, et al.
Publicado: (2016)

Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer: A Randomized Clinical Trial
por: Yu, Jiren, et al.
Publicado: (2022)

Patterns and predictors of recurrence after laparoscopic resection of rectal cancer
por: Yang, Hong, et al.
Publicado: (2022)

Quadruple‐editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS‐mutated colorectal cancer cells
por: Wang, Zaozao, et al.
Publicado: (2021)

Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study
por: Lee, Chang Min, et al.
Publicado: (2020)

Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry
por: Zhou, Chuanyong, et al.
Publicado: (2022)

Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis
por: Jeong, Sang-Ho, et al.
Publicado: (2022)

Comparison of adjuvant capecitabine plus oxaliplatin (CAPOX) versus S-1 after gastrectomy: a population-based cohort study using a nationwide claims database
por: Maeng, Chi Hoon, et al.
Publicado: (2023)

STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer
por: Wu, Fan, et al.
Publicado: (2018)

CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer
por: Wu, Wei, et al.
Publicado: (2017)

Massive gastrointestinal bleeding caused by a giant gastric inflammatory fibroid polyp: A case report
por: Zhang, Chenghai, et al.
Publicado: (2014)

Oncological results in rectal cancer patients with a subcentimetre distal margin after laparoscopic‐assisted sphincter‐preserving surgery
por: Zhang, Chenghai, et al.
Publicado: (2022)

Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China
por: Sah, Birendra Kumar, et al.
Publicado: (2021)

Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
por: Wang, Guoxiu, et al.
Publicado: (2018)

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer
por: Zhang, Yonglei, et al.
Publicado: (2021)

GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer
por: Liu, Xijuan, et al.
Publicado: (2015)

Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
por: Cho, Jang Ho, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ssdfo3pnle5ftl0gmlru3oiotn